Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed by a doctor with severe asthma (using standard medical guidelines called GINA criteria) and for whom a doctor has decided to start a biological medication — specifically one of: omalizumab, mepolizumab, benralizumab, dupilumab, or tezepelumab
Who may not be able to join:
- People who have a major surgery planned in the near future
- People with an active muscle or bone condition that prevents them from exercising regularly
- People whose level of exhaustion or fatigue would make it too difficult to attend appointments and follow an exercise plan
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mika Mäkelä, prof, Helsinki University Central Hospital
Phone: +358 40 6654484
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change in peak O2 consumption
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.